Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2008; Volume 73,Issue 5

Commentary

  • You have access
    Crystallizing Thinking about the β2-Adrenergic Receptor
    Arun K. Shukla, Jin-Peng Sun and Robert J. Lefkowitz
    Molecular Pharmacology May 2008, 73 (5) 1333-1338; DOI: https://doi.org/10.1124/mol.108.045849

Perspectives

  • You have access
    Messing Up with Traffic: Different Effects of Antipsychotic Agents on Glutamate Receptor Complexes in Vivo
    Thomas Del'guidice and Jean-Martin Beaulieu
    Molecular Pharmacology May 2008, 73 (5) 1339-1342; DOI: https://doi.org/10.1124/mol.108.046540
  • You have access
    P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?
    Robert W. Robey, Alberto Lazarowski and Susan E. Bates
    Molecular Pharmacology May 2008, 73 (5) 1343-1346; DOI: https://doi.org/10.1124/mol.108.046680

Accelerated Communications

  • You have access
    Acridinediones: Selective and Potent Inhibitors of the Malaria Parasite Mitochondrial bc1 Complex
    Giancarlo A. Biagini, Nicholas Fisher, Neil Berry, Paul A. Stocks, Brigitte Meunier, Dominic P. Williams, Richard Bonar-Law, Patrick G. Bray, Andrew Owen, Paul M. O'Neill and Stephen A. Ward
    Molecular Pharmacology May 2008, 73 (5) 1347-1355; DOI: https://doi.org/10.1124/mol.108.045120
  • You have access
    Regulation of Smad-Mediated Gene Transcription by RGS3
    Douglas M. Yau, Nan Sethakorn, Sebastien Taurin, Steven Kregel, Nathan Sandbo, Blanca Camoretti-Mercado, Anne I. Sperling and Nickolai O. Dulin
    Molecular Pharmacology May 2008, 73 (5) 1356-1361; DOI: https://doi.org/10.1124/mol.108.044990

Articles

  • You have access
    The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization
    Aron Chakera, Ruth M. Seeber, Alison E. John, Karin A. Eidne and David R. Greaves
    Molecular Pharmacology May 2008, 73 (5) 1362-1370; DOI: https://doi.org/10.1124/mol.107.040915
  • You have access
    Allosteric Ligands for the Corticotropin Releasing Factor Type 1 Receptor Modulate Conformational States Involved in Receptor Activation
    Sam R. J. Hoare, Beth A. Fleck, Raymond S. Gross, Paul D. Crowe, John P. Williams and Dimitri E. Grigoriadis
    Molecular Pharmacology May 2008, 73 (5) 1371-1380; DOI: https://doi.org/10.1124/mol.107.042978
  • You have access
    Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis
    Ajaib Singh Paintlia, Manjeet Kaur Paintlia, Avtar Kaur Singh and Inderjit Singh
    Molecular Pharmacology May 2008, 73 (5) 1381-1393; DOI: https://doi.org/10.1124/mol.107.044230
  • You have access
    Tumor Necrosis Factor-α Regulates Inflammatory and Mesenchymal Responses via Mitogen-Activated Protein Kinase Kinase, p38, and Nuclear Factor κB in Human Endometriotic Epithelial Cells
    Eric M. Grund, David Kagan, Cam Anh Tran, Andreas Zeitvogel, Anna Starzinski-Powitz, Selvaraj Nataraja and Stephen S. Palmer
    Molecular Pharmacology May 2008, 73 (5) 1394-1404; DOI: https://doi.org/10.1124/mol.107.042176
  • You have access
    Tissue-Specific Regulation of Microvascular Diameter: Opposite Functional Roles of Neuronal and Smooth Muscle Located Vanilloid Receptor-1
    Tamás Kark, Zsolt Bagi, Erzsébet Lizanecz, Enikő T. Pásztor, Nóra Erdei, Ágnes Czikora, Zoltán Papp, István Édes, Róbert Pórszász and Attila Tóth
    Molecular Pharmacology May 2008, 73 (5) 1405-1412; DOI: https://doi.org/10.1124/mol.107.043323
  • You have access
    Slc39a14 Gene Encodes ZIP14, A Metal/Bicarbonate Symporter: Similarities to the ZIP8 Transporter
    Kuppuswami Girijashanker, Lei He, Manoocher Soleimani, Jodie M. Reed, Hong Li, Zhiwei Liu, Bin Wang, Timothy P. Dalton and Daniel W. Nebert
    Molecular Pharmacology May 2008, 73 (5) 1413-1423; DOI: https://doi.org/10.1124/mol.107.043588
  • You have access
    Simvastatin Protects against Amyloid β and HIV-1 Tat-Induced Promoter Activities of Inflammatory Genes in Brain Endothelial Cells
    Ibolya E. András, GeunBae Rha, Wen Huang, SungYong Eum, Pierre-Olivier Couraud, Ignacio A. Romero, Bernhard Hennig and Michal Toborek
    Molecular Pharmacology May 2008, 73 (5) 1424-1433; DOI: https://doi.org/10.1124/mol.107.042028
  • You have access
    In Vivo Imaging Reveals Selective Peroxisome Proliferator Activated Receptor Modulator Activity of the Synthetic Ligand 3-(1-(4-Chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886)
    Andrea Biserni, Fabio Giannessi, Anna Floriana Sciarroni, Ferdinando Maria Milazzo, Adriana Maggi and Paolo Ciana
    Molecular Pharmacology May 2008, 73 (5) 1434-1443; DOI: https://doi.org/10.1124/mol.107.042689
  • You have access
    Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling
    Björn Bauer, Anika M. S. Hartz, Anton Pekcec, Kathrin Toellner, David S. Miller and Heidrun Potschka
    Molecular Pharmacology May 2008, 73 (5) 1444-1453; DOI: https://doi.org/10.1124/mol.107.041210
  • You have access
    Tumor Necrosis Factor-α Enhances Neutrophil Adhesiveness: Induction of Vascular Cell Adhesion Molecule-1 via Activation of Akt and CaM Kinase II and Modifications of Histone Acetyltransferase and Histone Deacetylase 4 in Human Tracheal Smooth Muscle Cells
    Chiang-Wen Lee, Chih-Chung Lin, Shue-Fen Luo, Hui-Chun Lee, I.-Ta Lee, William C. Aird, Tsong-Long Hwang and Chuen-Mao Yang
    Molecular Pharmacology May 2008, 73 (5) 1454-1464; DOI: https://doi.org/10.1124/mol.107.038091
  • You have access
    Epigallocatechin-3-gallate Inhibits Growth of Activated Hepatic Stellate Cells by Enhancing the Capacity of Glutathione Synthesis
    Yumei Fu, Shizhong Zheng, Shelly C. Lu and Anping Chen
    Molecular Pharmacology May 2008, 73 (5) 1465-1473; DOI: https://doi.org/10.1124/mol.107.040634
  • You have access
    Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine
    Soichiro Matsushima, Kazuya Maeda, Hisamitsu Hayashi, Yasuyuki Debori, Alfred H. Schinkel, John D. Schuetz, Hiroyuki Kusuhara and Yuichi Sugiyama
    Molecular Pharmacology May 2008, 73 (5) 1474-1483; DOI: https://doi.org/10.1124/mol.107.041459
  • You have access
    Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs
    Fabio Fumagalli, Angelisa Frasca, Giorgio Racagni and Marco Andrea Riva
    Molecular Pharmacology May 2008, 73 (5) 1484-1490; DOI: https://doi.org/10.1124/mol.107.043786
  • You have access
    The Chemopreventive Agent Curcumin Is a Potent Radiosensitizer of Human Cervical Tumor Cells via Increased Reactive Oxygen Species Production and Overactivation of the Mitogen-Activated Protein Kinase Pathway
    Prashanthi Javvadi, Andrew T. Segan, Stephen W. Tuttle and Constantinos Koumenis
    Molecular Pharmacology May 2008, 73 (5) 1491-1501; DOI: https://doi.org/10.1124/mol.107.043554
  • You have access
    Abrogation of Hyperosmotic Impairment of Insulin Signaling by a Novel Class of 1,2-Dithiole-3-thiones through the Inhibition of S6K1 Activation
    Eun Ju Bae, Yoon Mee Yang and Sang Geon Kim
    Molecular Pharmacology May 2008, 73 (5) 1502-1512; DOI: https://doi.org/10.1124/mol.107.044347
  • You have access
    Translocation of Glycosylphosphatidylinositol-Anchored Proteins from Plasma Membrane Microdomains to Lipid Droplets in Rat Adipocytes Is Induced by Palmitate, H2O2, and the Sulfonylurea Drug Glimepiride
    Günter Müller, Susanne Wied, Nicole Walz and Christian Jung
    Molecular Pharmacology May 2008, 73 (5) 1513-1529; DOI: https://doi.org/10.1124/mol.107.043935
  • You have access
    Interleukin 13 Increases Contractility of Murine Tracheal Smooth Muscle by a Phosphoinositide 3-kinase p110δ-Dependent Mechanism
    Hanan S. M. Farghaly, Ian S. Blagbrough, David A. Medina-Tato and Malcolm L. Watson
    Molecular Pharmacology May 2008, 73 (5) 1530-1537; DOI: https://doi.org/10.1124/mol.108.045419
  • You have access
    Endogenous Regulators of G Protein Signaling Differentially Modulate Full and Partial μ-Opioid Agonists at Adenylyl Cyclase as Predicted by a Collision Coupling Model
    M. J. Clark, J. J. Linderman and J. R. Traynor
    Molecular Pharmacology May 2008, 73 (5) 1538-1548; DOI: https://doi.org/10.1124/mol.107.043547
  • You have access
    RETRACTION: Flavopiridol Suppresses Tumor Necrosis Factor-Induced Activation of Activator Protein-1, c-Jun N-Terminal Kinase, p38 Mitogen-Activated Protein Kinase (MAPK), p44/p42 MAPK, and Akt, Inhibits Expression of Antiapoptotic Gene Products, and Enhances Apoptosis through Cytochrome c Release and Caspase Activation in Human Myeloid Cells
    Yasunari Takada, Gautam Sethi, Bokyung Sung and Bharat B. Aggarwal
    Molecular Pharmacology May 2008, 73 (5) 1549-1557; DOI: https://doi.org/10.1124/mol.107.041350
  • You have access
    Interaction of Heterogeneous Nuclear Ribonucleoprotein C1/C2 with a Novel cis-Regulatory Element within p53 mRNA as a Response to Cytostatic Drug Treatment
    Kyle J. Christian, Matti A. Lang and Françoise Raffalli-Mathieu
    Molecular Pharmacology May 2008, 73 (5) 1558-1567; DOI: https://doi.org/10.1124/mol.107.042507
  • You have access
    Targeting MDR1 Gene: Synthesis and Cellular Study of Modified Daunomycin-Triplex-Forming Oligonucleotide Conjugates Able to Inhibit Gene Expression in Resistant Cell Lines
    Vérène Stierlé, Maria Duca, Ludovic Halby, Catherine Senamaud-Beaufort, Massimo L. Capobianco, Alain Laigle, Béatrice Jollès and Paola B. Arimondo
    Molecular Pharmacology May 2008, 73 (5) 1568-1577; DOI: https://doi.org/10.1124/mol.107.042010
  • You have access
    Discovery of a Quorum-Sensing Inhibitor of Drug-Resistant Staphylococcal Infections by Structure-Based Virtual Screening
    Madanahally D. Kiran, Nallini Vijayarangan Adikesavan, Oscar Cirioni, Andrea Giacometti, Carmela Silvestri, Giorgio Scalise, Roberto Ghiselli, Vittorio Saba, Fiorenza Orlando, Menachem Shoham and Naomi Balaban
    Molecular Pharmacology May 2008, 73 (5) 1578-1586; DOI: https://doi.org/10.1124/mol.107.044164

Erratum

  • You have access
    Correction to “The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine”
    Molecular Pharmacology May 2008, 73 (5) 1587; DOI: https://doi.org/10.1124/mol.73.5.1587
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 73 (5)
Molecular Pharmacology
Vol. 73, Issue 5
1 May 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Commentary
  • Perspectives
  • Accelerated Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics